Canine oral squamous cell carcinoma
Ontology highlight
ABSTRACT:
INSTRUMENT(S): Illumina CanineHD
ORGANISM(S): Canis Lupus Familiaris
SUBMITTER: Cornell University
PROVIDER: PRJEB77007 | EVA | 2024-06-30
REPOSITORIES: EVA
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| COSCC_168_fingerprint_ref2.accessioned.vcf.gz | Vcf | |||
| COSCC_168_fingerprint_ref2.accessioned.vcf.gz.csi | Vcf | |||
| COSCC_168_fingerprint_ref2.vcf.csi | Other | |||
| COSCC_168_fingerprint_ref2.vcf.gz | Vcf |
Items per page: 5 1 - 4 of 4 |
Similar Datasets
Project description:Spatial Transcriptomic Landscape of Canine Oral Squamous Cell Carcinoma
| PRJNA1237687 | ENA
Project description:Spontaneous canine head and neck squamous cell carcinoma (HNSCC) represents an excellent model of human HNSCC but is greatly understudied. To better understand and utilize this valuable resource, we performed a pilot study that represents its first genome-wide characterization by investigating 12 canine HNSCC cases, of which 9 are oral, via high density array comparative genomic hybridization and RNA-seq. The analyses reveal that these canine cancers recapitulate many molecular features of human HNSCC. These include analogous genomic copy number abnormality landscapes and sequence mutation patterns, recurrent alteration of known HNSCC genes and pathways (e.g., cell cycle, PI3K/AKT signaling), and comparably extensive heterogeneity. Amplification or overexpression of protein kinase genes, matrix metalloproteinase genes, and epithelial–mesenchymal transition genes TWIST1 and SNAI1 are also prominent in these canine tumors. This pilot study, along with a rapidly growing body of literature on canine cancer, reemphasizes the potential value of spontaneous canine cancers in HNSCC basic and translational research.
2015-06-02 | GSE61231 | GEO
Project description:Canine Oral Squamous Cell Carcinoma (COSCC) is the second most common oral tumor in dogs, and the most relevant for comparative human trials as a spontaneous large animal model of disease. Thus, complete knowledge of the genomic landscape is essential for identifying therapeutic vulnerabilities and early biomarkers of disease across species. Historical genomic work has focused primarily on bulk sequencing, with only one publication using a laser capture dissection technique. The present study describes the complete molecular landscape of COSCC with spatial distinction between the surface tumor, deep invasive front, tumor microenvironment, and peritumoral dysplasia compared to matched normal samples. Each region demonstrated distinct molecular signatures. Genes related to epithelial growth factor (EGFR) and epithelial mesenchymal transformation (EMT) were upregulated in peri-tumoral dysplasia and surface cancer. Additionally, KRAS, SSP1 and KRT14 were upregulated in cancer, therefore combining these read outs may be useful in differentiating high grade dysplasia from malignant tissue at a molecular level. The primary tumor infiltrating leukocyte present in the tumor stroma were M2 macrophages. IL-10 expression was also significantly higher in the stroma, suggesting that tumor associated macrophages were directly related to establishing an immunosuppressive environment via cytokine secretion. The other predominant leukocytes were T-cells, with CD4+ T-cells being most common. CD4+ T cells expressed transcripts for both stimulatory (adaptive immunity with B cells and ICOS) and inhibitory molecules (CTLA4). However, the observed increase in CTLA4 suggests that this inhibitory signal may be preventing a robust anti-tumor immune response representing a therapeutic target for COSCC.
2025-06-26 | GSE292226 | GEO
Project description:Background Leukemia/lymphoma cell lines have been critical in the investigation of the pathogenesis and therapy of hematological malignancies. While human LL cell lines have generally been found to recapitulate the primary tumors from which they were derived, appropriate characterization including cytogenetic and transcriptional assessment is crucial for assessing their clinical predictive value. Results In the following study, five canine LL cell lines, CLBL-1, Ema, TL-1 (Nody-1), UL-1, and 3132, were characterized using extensive immunophenotyping, karyotypic analysis, oligonucleotide array comparative genomic hybridization (oaCGH), and gene expression profiling. Genome-wide DNA copy number data from the cell lines were also directly compared with 299 primary canine round cell tumors to determine whether the cell lines represent primary tumors, and, if so, what subtype each most closely resembled. Discussion Based on integrated analyses, CLBL-1 was classified as B-cell lymphoma, Ema and TL-1 as T-cell lymphoma, and UL-1 as T-cell acute lymphoblastic leukemia. 3132, originally classified as a B-cell lymphoma, was reclassified as a histiocytic sarcoma based on characteristic cytogenomic properties. In combination, these data begin to elucidate the clinical predictive value of these cell lines which will enhance the appropriate selection of in vitro models for future studies of canine hematological malignancies. GEP using GeneChip Canine Genome 2.0 array (Affymetrix, Santa Clara, CA) Five canine lymphoid cell lines analyzed
2016-08-19 | E-GEOD-85720 | biostudies-arrayexpress
Project description:Background Leukemia/lymphoma cell lines have been critical in the investigation of the pathogenesis and therapy of hematological malignancies. While human LL cell lines have generally been found to recapitulate the primary tumors from which they were derived, appropriate characterization including cytogenetic and transcriptional assessment is crucial for assessing their clinical predictive value. Results In the following study, five canine LL cell lines, CLBL-1, Ema, TL-1 (Nody-1), UL-1, and 3132, were characterized using extensive immunophenotyping, karyotypic analysis, oligonucleotide array comparative genomic hybridization (oaCGH), and gene expression profiling. Genome-wide DNA copy number data from the cell lines were also directly compared with 299 primary canine round cell tumors to determine whether the cell lines represent primary tumors, and, if so, what subtype each most closely resembled. Discussion Based on integrated analyses, CLBL-1 was classified as B-cell lymphoma, Ema and TL-1 as T-cell lymphoma, and UL-1 as T-cell acute lymphoblastic leukemia. 3132, originally classified as a B-cell lymphoma, was reclassified as a histiocytic sarcoma based on characteristic cytogenomic properties. In combination, these data begin to elucidate the clinical predictive value of these cell lines which will enhance the appropriate selection of in vitro models for future studies of canine hematological malignancies. GEP using GeneChip Canine Genome 2.0 array (Affymetrix, Santa Clara, CA)
2016-08-19 | GSE85720 | GEO
Project description:We report single-cell RNA sequencing of 54,607 cells from 3 canine meningioma and 2 canine dura samples.
2024-05-03 | GSE224723 | GEO
Project description:Cancer cell line panels that incorporate genomic and pharmacologic screening data have become powerful tools for investigating the relationship between gene expression and drug response in human cancer research. Similar cell line panels of such a scale as the NCI60, CCLE, or GDSC do not currently exist in canine cancer research. Here we have assembled a canine cancer cell line panel of 29 cell lines representing multiple tumor types that have undergone gene expression profiling and have begun to be used for pharmacologic screening. RNA was extracted from drug naïve canine cancer cell lines and subjected to microarray analysis.
2015-12-18 | E-GEOD-76126 | biostudies-arrayexpress
Project description:Pet dogs may provide a useful large-animal model of spontaneously occuring non-Hodgkin lymphoma, but complete molecular characterization is lacking. We used gene expression microarrays to molecularly characterize canine lymphoma, and found similarities between canine B-cell lymphoma and human diffuse large B-cell lymphoma.
2013-07-02 | GSE43664 | GEO
Project description:Cell lines and tumor tissues from canine hemangiosarcoma derived cell lines and hemangiosarcoma tissue samples
2014-12-08 | GSE46040 | GEO
Project description:Cell lines and tumor tissues from canine osteosarcomas with accompanying survival and breed data.
2011-09-08 | GSE27217 | GEO